- In April 2024, iThera Medical GmbH, a leading innovator in photoacoustic imaging, launched its next-generation inVision TRIO system. This preclinical imaging platform features improved image resolution and enhanced multispectral capabilities, enabling researchers to conduct more precise and efficient studies in oncology and inflammation. The upgrade reinforces iThera’s leadership in advancing translational imaging and expanding the applications of photoacoustic tomography in biomedical research
- In March 2024, FUJIFILM VisualSonics announced the integration of artificial intelligence into its Vevo LAZR-X photoacoustic imaging system. This development aims to enhance real-time image analysis and automate tissue characterization, significantly improving diagnostic accuracy in preclinical and clinical research. The AI-powered system enables researchers to quickly detect anomalies and streamline image interpretation, reflecting FUJIFILM’s ongoing commitment to innovation in non-invasive imaging
- In February 2024, ENDRA Life Sciences Inc. partnered with the University of Michigan to conduct a pilot clinical study evaluating its TAEUS® platform for liver disease detection using photoacoustic technology. The study marks a significant step in transitioning photoacoustic tomography from research to clinical settings, with the goal of offering a non-invasive, cost-effective alternative to traditional imaging modalities such as MRI and CT in detecting non-alcoholic fatty liver disease (NAFLD)
- In January 2024, Bruker Corporation expanded its photoacoustic product portfolio by acquiring a startup specializing in optical-acoustic sensor integration. The acquisition is expected to enhance Bruker’s capabilities in multimodal imaging systems by combining expertise in optical detection and acoustic signal processing, thereby strengthening its position in the biomedical imaging market
- In December 2023, kibero GmbH, a Germany-based provider of photoacoustic imaging solutions, introduced a portable, handheld photoacoustic tomography device aimed at point-of-care diagnostics. This device enables rapid assessment of superficial vascular and dermatological conditions in outpatient settings and emergency rooms. The launch supports kibero’s mission to make advanced imaging more accessible and practical for real-world clinical applications
